Shareholding20 Aug 2026, 09:27 am
Sudhir Sethi Acquires 0.10% Stake in Beryl Drugs
AI Summary
Sudhir Sethi, a promoter of Beryl Drugs Ltd, has acquired 4,809 shares, representing 0.10% of the company's total voting capital. This acquisition increases his total shareholding to 518,928 shares, or 10.24% of the total equity. The transaction was conducted through market transactions. The disclosure was made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Highlights
- Promoter Sudhir Sethi acquired 4,809 shares.
- Acquisition represents 0.10% of total voting capital.
- Sethi's total holding increases to 10.24%.
- Transaction occurred via market purchases.
- Disclosure filed under SEBI Takeover Regulations.
Price Impact
More from BERLDRG